Sumitomo Dainippon (Germany) Profile

18.30
EUR 0.05  0.27%
94%
0%

Sumitomo Dainippon Summary

Sumitomo Dainippon Pharma Co Ltd (DPM) is traded on Frankfurt Stock Exchange in Germany. It is located in 6-8 Doshomachi 2-chome and employs 6,268 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 7.67 B. Sumitomo Dainippon Pharma Co Ltd has 397.3 M outstanding shares. DAINIP S'TOMO PHA has accumulated about 1.34 B in cash with 848.35 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.38.
Check Sumitomo Dainippon Probability Of Bankruptcy

Sumitomo Dainippon Target Price Odds Analysis

Odds Below 18.3HorizonTargetOdds Above 18.3
92.71%30 days 18.30 7.18%
Based on normal probability distribution, the odds of Sumitomo Dainippon to move above current price in 30 days from now is about 7.18% (This Sumitomo Dainippon Pharma Co Ltd probability density function shows the probability of Sumitomo Dainippon Stock to fall within a particular range of prices over 30 days) .

Sumitomo Dainippon Risk Profiles

Sumitomo Dainippon Key Fundamentals

Sumitomo Dainippon Against Markets

Sumitomo Dainippon Current Ratings

Sumitomo Dainippon Pharma Co Ltd 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
7 
Chance of
Financial Distress (0 to 100%)
23 
Equity ratings for Sumitomo Dainippon Pharma Co Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients, food additives, veterinary medicines, diagnostics, and others. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Sumitomo Dainippon operates under Drug Manufacturers - Specialty Generic classification in Germany and traded on Frankfurt Stock Exchange. It employs 6268 people. more
NameSumitomo Dainippon Pharma Co Ltd
CEOJonathan GoodmanView All
Macroaxis Advice
InstrumentGermany Stock View All
Business Address6-8 Doshomachi 2-chome
Foreign Associate  USA
ExchangeFrankfurt Stock Exchange
SectorHealthcare
BenchmarkDOW
Websitewww.ds-pharma.com
Phone81 6 6203 5321
CurrencyEUR - Euro

Sumitomo Dainippon Directors

Sumitomo Dainippon Corporate Directors

Peter Nixon Independent Director
Peter Gillin Lead Independent Director
MarieAnne Tawil Director
Additionally see Investing Opportunities. Please also try Portfolio Quick Import module to import or update all your transactions via one easy-to-use interface.
Search macroaxis.com